<DOC>
	<DOCNO>NCT00409487</DOCNO>
	<brief_summary>The main objective study compare decrease mean arterial blood pressure 24 hour patient obstructive sleep apnea syndrome weak moderate hypertension , treat Valsartan 160mg per day versus continuous Positive Airway Pressure .</brief_summary>
	<brief_title>Effects Continuous Positive Airway Pressure Valsartan Treatments Arterial Blood Pressure OSAS Patients</brief_title>
	<detailed_description>It well known cardiovascular risk increase patient obstructive sleep apnea syndrome ( OSAS ) . Also link already demonstrate OSAS hypertension . Nowadays , efficient treatment OSAS continuous Positive Airway Pressure ( cPAP ) . Several study also show cPAP could reduce arterial blood pressure 3,3 mmHg OSAS patient . Unfortunately , 40 % patient either refuse treat cPAP give treatment . In parallel , alternative medication propose patient moderate OSAS hypertension , order decrease cardiovascular risk . A study lead rat show superiority beta adrenergic block agent decrease hypertension OSAS patient . Our study also objective compare effect Valsartan cPAP hypertension OSAS patient . Those one randomize either group `` treatment Valsartan cPAP '' group `` treatment cPAP Valsartan '' ( cross-over study ) .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>male/female 18 year old patient obstructive sleep apnea ( apneahypopnea index &gt; equal 15 ) patient weak moderate hypertension ( 140 &lt; = SBP &lt; 180 mmHg 90 &lt; = DBP &lt; 110 mmHg ) . Patient antihypertensive monotherapy must stop treatment respect washout period least 4 week screen visit . For patient treat antialdosterone , washout period least 8 week . negative pregnancy test ambulatory patient patient sign informed consent form patient affiliate social security pregnant nursing woman woman refuse use contraceptive method acute hepatic failure , biliary cirrhosis , cholestasis clearance Cockcroft &lt; 30 ml/min/1.73m2 kaliemia &gt; = 5.5 mmol/l acute hypertension ( SBP &gt; = 180 mmHg and/or DBP &gt; = 110 mmHg ) acute daytime sleepiness ( Epworth rating scale &gt; 15 ) patient profession inconsistent continuous positive airway pressure ( CPAP ) treatment know cardiovascular pathology contraindication CPAP allergy Valsartan patient treat lithium patient treat drug ( ) act arterial blood pressure patient tutelle curatelle patient keep detention , major protect law , hospitalise person patient currently participate another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>obstructive sleep apnea</keyword>
	<keyword>hypertension</keyword>
	<keyword>ambulatory bloop pressure monitoring</keyword>
</DOC>